HHS pulls guidance on reproductive health drug access

HHS has rescinded a civil rights guidance directed at the nation’s retail pharmacies, reversing a directive that outlined their legal obligations to dispense medications tied to reproductive health. HHS’ Office for Civil Rights withdrew its September 2023 guidance, which had updated a 2022 version addressing sex and disability discrimination under federal law, according to a […]

Continue Reading

How 14 health systems plan on aligning quality, safety, and financial performance in 2026

Becker’s asked 14 healthcare leaders what steps they’re taking to align quality, Safety, and financial performance in 2026. The leaders featured below are speaking at Becker’s Perioperative Summit, Sept. 14-Sep. 15, 2026, at the Hilton Chicago. If you would like to join the event as a speaker, please contact Scott King at sking@beckershealthcare.com. As part of […]

Continue Reading

Her Son’s Injury Never Got Its Day in Vaccine Court. Their Lawyer Is Now Advising RFK Jr. on Its Overhaul.

JACKSONVILLE, Fla. — In 2019, after a routine vaccination, 11-year-old Keithron Thomas felt a sharp pain in his shoulder and down his arm. His mother, Melanie Bostic, thought it would go away after a few days. But days turned to weeks, then months, and years. Bostic learned of a federal program designed to help people […]

Continue Reading

Medicare Advantage Insurers Face New Curbs on Overcharges in Trump Plan That Reins in Payments

Medicare Advantage health plans are blasting a government proposal this week that would keep their reimbursement rates flat next year while making other payment changes. But some health policy experts say the plan could help reduce billions of dollars in overcharges that have been common in the program for more than a decade. On Jan. […]

Continue Reading

Lilly inks $1.1B gene therapy deal for hearing loss

Eli Lilly has entered a global research collaboration and licensing agreement with Seamless Therapeutics to develop programmable recombinase-based gene therapies for genetic hearing loss. Under the deal, Lilly secured exclusive rights to site-specific recombinases programmed by Seamless to target gene mutations associated with hearing loss, according to a Jan. 28 news release from Seamless Therapeutics. […]

Continue Reading

14 recent hospital, health system CEO moves

Hospital and health system CEOs across the U.S. have made several moves recently, including appointments at new organizations and departures. Some executives have remained with their organizations in expanded roles overseeing multiple facilities, as some systems eliminate individual hospital CEO positions in favor of regional leadership models.  Meanwhile, CEO turnover — including retirements and resignations […]

Continue Reading

HHS outlines path for lower-cost drugs via direct sales

The Department of Health and Human Services issued a special advisory bulletin clarifying that pharmaceutical manufacturers may sell lower-cost prescription drugs directly to Medicare and Medicaid patients without violating the Anti-Kickback Statute, provided that specific safeguards are met. The guidance, issued by HHS’ Office of Inspector General on Jan. 27, outlines criteria that “lower the […]

Continue Reading